Detalhe da pesquisa
1.
Observational study of everolimus plus exemestane in postmenopausal women with hormone receptor-positive, HER2-negative advanced breast cancer.
Acta Oncol
; 58(3): 385-387, 2019 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-30798641
2.
Historical Biobanks in Breast Cancer Metabolomics- Challenges and Opportunities.
Metabolites
; 9(11)2019 Nov 13.
Artigo
Inglês
| MEDLINE | ID: mdl-31766128
3.
DNA methylation signature (SAM40) identifies subgroups of the Luminal A breast cancer samples with distinct survival.
Oncotarget
; 8(1): 1074-1082, 2017 Jan 03.
Artigo
Inglês
| MEDLINE | ID: mdl-27911866
4.
Reduction in bone relapse and improved survival with oral clodronate for adjuvant treatment of operable breast cancer [ISRCTN83688026].
Breast Cancer Res
; 8(2): R13, 2006.
Artigo
Inglês
| MEDLINE | ID: mdl-16542503
5.
Radiation-induced effects on gene expression: an in vivo study on breast cancer.
Radiother Oncol
; 80(2): 230-5, 2006 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-16890317
6.
Randomized, placebo-controlled trial of clodronate in patients with primary operable breast cancer.
J Clin Oncol
; 20(15): 3219-24, 2002 Aug 01.
Artigo
Inglês
| MEDLINE | ID: mdl-12149294
7.
[Breast cancer patients' assessment of waiting time before radiotherapy]. / Brystkreftpasienters vurdering av ventetid før strålebehandling.
Tidsskr Nor Laegeforen
; 123(12): 1685-6, 2003 Jun 12.
Artigo
Norueguês
| MEDLINE | ID: mdl-12821991
8.
Systematic analysis of challenge-driven improvements in molecular prognostic models for breast cancer.
Sci Transl Med
; 5(181): 181re1, 2013 Apr 17.
Artigo
Inglês
| MEDLINE | ID: mdl-23596205
9.
Gefitinib in Combination with Weekly Docetaxel in Patients with Metastatic Breast Cancer Caused Unexpected Toxicity: Results from a Randomized Phase II Clinical Trial.
ISRN Oncol
; 2012: 176789, 2012.
Artigo
Inglês
| MEDLINE | ID: mdl-22666610